Anti-inflammatory therapy in chronic disease: challenges and opportunities
about
Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variantsDoes the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox?Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary MyelofibrosisAnimal models to study acute and chronic intestinal inflammation in mammalsFibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse modelsInhibition of microglia activation as a phenotypic assay in early drug discoveryImaging and nanomedicine in inflammatory atherosclerosisBurn wound healing and treatment: review and advancementsIntermittent or sustained systemic inflammation and the preterm brainAtherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging.Phagocyte-myocyte interactions and consequences during hypoxic wound healing.The Immune System in Tissue Environments Regaining Homeostasis after Injury: Is "Inflammation" Always Inflammation?Artery Tertiary Lymphoid Organs: Powerhouses of Atherosclerosis Immunity.Anti-Inflammatory Activity of Citrus bergamia Derivatives: Where Do We Stand?Current and Emerging Uses of Statins in Clinical Therapeutics: A ReviewHeterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and RepairImaging Nanotherapeutics in Inflamed Vasculature by Intravital MicroscopyThe sinonasal bacterial microbiome in health and diseaseLipid mediators in the resolution of inflammationProresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolventIdentification of resolvin D2 receptor mediating resolution of infections and organ protectionElucidation of novel 13-series resolvins that increase with atorvastatin and clear infectionsEffect of Different Omega-6/Omega-3 Polyunsaturated Fatty Acid Ratios on the Formation of Monohydroxylated Fatty Acids in THP-1 Derived MacrophagesMaresin 1 biosynthesis during platelet-neutrophil interactions is organ-protectiveProtectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomeMaresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophagesMolecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic targetTranslational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory DiseasesA Zebrafish Drug-Repurposing Screen Reveals sGC-Dependent and sGC-Independent Pro-Inflammatory Activities of Nitric OxideIdentification and Actions of a Novel Third Maresin Conjugate in Tissue Regeneration: MCTR3Inflammation-a Critical Appreciation of the Role of Myeloid CellsResolution of acute inflammation in the lungNovel translational model of resolving inflammation triggered by UV-killed E. coliA nontoxic pain killer designed by modeling of pathological receptor conformations.Recent insights into the cellular biology of atherosclerosisPrevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue InflammationThe reverse-direction method links mass experimental data to human diseases.Synthesis and anti-inflammatory and pro-resolving activities of 22-OH-PD1, a monohydroxylated metabolite of protectin D1.Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation
P2860
Q24273409-D69BA30C-5F83-4CD7-9F86-CD3EA2E4F4D1Q26765800-80422430-6BDC-41E3-8D0C-B14235F1CBA7Q26774212-D9A6F935-590E-4C9A-B17D-3804B423B396Q26777430-62C5837C-55D4-49E1-9250-03D7C6DEC74EQ26994661-35B5829A-B186-4613-8627-47D3169EE26CQ26996061-0B050484-280D-4156-BB42-4A83D23C1896Q27002916-C6BB0380-6D4F-4548-8A61-32E075B7225DQ27013939-2830E8E4-376A-4996-9C7B-5556BC60BFD8Q27014887-4CCE1ABE-AD48-4FC6-8A4C-B957CA1EB8BAQ27334823-8A831A58-A9B7-4059-A0EC-7830C401E8CDQ27690914-37538C84-44CE-4A55-9A26-BAC6E83CB911Q28066426-7B0C495C-9442-4244-B805-42B7C954F8ECQ28072367-BE813C1A-BB9B-434D-98B9-0766D80D6B65Q28075161-2CF79DDA-D396-4BBC-A38A-763D8C8C0666Q28076346-6D880FB8-1FB1-467F-85C1-6BBB64B8FB94Q28078211-36BC40E2-A272-464D-96D8-668B0B9B5CA7Q28080268-E371E6A9-E56B-4EF9-8BEA-018680180DF0Q28081348-6F433FDC-D921-43C0-BE9E-F9B13AE9F8D5Q28250668-D76C3A84-E4FB-424C-93E6-CA320A8A72B4Q28258840-B20EE275-4A9B-4AB7-8A78-CF942BAD8BF1Q28265395-A8A203FF-296F-4B70-B516-6120479FE70BQ28265796-CBD333F8-6B4D-4B42-BA62-48A247F157D5Q28383078-E8F7BC5C-C559-48D9-9C72-D199CE8B7792Q28383169-6BFEA3FC-A0E4-4948-98EA-3FECA747AF99Q28387661-E83AA1A3-944E-43F2-9EF7-D4CE168A6D8EQ28390502-0C0AF05C-5B35-412A-8559-BC08A5454A91Q28393356-D79515D4-6EF8-4F20-835D-EA47C4FBE2A3Q28548580-6D5849A9-B001-4525-ABE9-53CE2B45D584Q28550118-90C24C11-CA61-472D-84FF-182966744525Q28550214-524467CB-F0B9-42EC-8125-59BE02E30F3EQ28595434-A2C8E37D-81D0-46D8-A578-5120F618B395Q28652204-F6FC26D0-88DA-43D9-907D-88EA349680F0Q28829177-D124C4D3-B36E-4337-9C80-050F94CC3C28Q29479930-4D3173D8-962F-46FE-83B5-12FC917B0F5EQ30300194-2C5D54CF-E2B0-4ADD-827B-EF4D457C1B8DQ30583848-3DE6C8B5-236F-4624-B0A8-A0E94DA47AE5Q30657993-26F228F6-E4B8-4851-9EB2-8984306DA697Q30664511-E6BFA839-9E77-44B2-9810-F0BE4DA7D486Q30854633-169997F6-DBCF-47B7-B284-31EFF389E919Q31122092-3291721E-9ECD-4123-BB0E-A48580C73555
P2860
Anti-inflammatory therapy in chronic disease: challenges and opportunities
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Anti-inflammatory therapy in chronic disease: challenges and opportunities
@ast
Anti-inflammatory therapy in chronic disease: challenges and opportunities
@en
Anti-inflammatory therapy in chronic disease: challenges and opportunities
@nl
type
label
Anti-inflammatory therapy in chronic disease: challenges and opportunities
@ast
Anti-inflammatory therapy in chronic disease: challenges and opportunities
@en
Anti-inflammatory therapy in chronic disease: challenges and opportunities
@nl
prefLabel
Anti-inflammatory therapy in chronic disease: challenges and opportunities
@ast
Anti-inflammatory therapy in chronic disease: challenges and opportunities
@en
Anti-inflammatory therapy in chronic disease: challenges and opportunities
@nl
P2860
P3181
P356
P1433
P1476
Anti-inflammatory therapy in chronic disease: challenges and opportunities
@en
P2093
P2860
P304
P3181
P356
10.1126/SCIENCE.1230720
P407
P577
2013-01-11T00:00:00Z